About Cell Sorts — Magnetic Cell Sorting Technology Leader
Cell Sorts provides life science researchers and biopharmaceutical companies worldwide with high-quality, cost-effective magnetic cell sorting solutions. Our column-free and column-based kits make immune cell isolation simpler, faster, and more reliable — delivering 90–99% purity in 15–30 minutes.
Leading Magnetic Cell Sorting Technology
Cell Sorts is a high-tech enterprise specializing in magnetic cell sorting technology, headquartered at the NJ Bioscience Center in Trenton, New Jersey. Our team comprises top scientists and engineers from immunology, cell biology, and materials science.
We have independently developed four technology platforms — column-free negative selection, column-free positive selection, column-based negative selection, and column-based positive selection — launching over 60 cell sorting kit products covering major human and mouse immune cell types to meet full-scenario needs from basic research to clinical translation.
Cell Sorts products have served hundreds of research institutions, biopharmaceutical companies, and clinical research centers worldwide, helping clients achieve breakthrough results in immunology, oncology, cell therapy, and regenerative medicine.
Contact UsWhy Choose Cell Sorts
Driving Scientific Discovery Through Magnetic Cell Sorting Innovation
Independent R&D
Complete intellectual property system for magnetic cell sorting technology, with core magnetic bead and buffer formulations all independently developed in-house.
Fast & Efficient
Complete cell sorting in 15–30 minutes with 90–99% purity. No lengthy waiting or complex operational procedures — just simple pour-off collection.
Quality Assurance
Rigorous quality control system ensuring batch-to-batch consistency with stable sorting purity of 90–99% and >95% cell viability.
Expert Team
Senior immunology and cell biology experts provide comprehensive technical support from protocol optimization to troubleshooting.
Full-Scenario Coverage
Four technology platforms and 60+ products covering human and mouse immune cells — from CD4+ T cells to B cells, NK cells, monocytes, and neutrophils.
Continuous Innovation
Continuous R&D investment, constantly launching new products and technologies to lead industry development in cell separation and immunotherapy research.